scholarly journals Long-term Local Control of Primary Non-small Cell Lung Cancer and Adrenal Oligometastasis with Stereotactic Body Radiotherapy: A Case Report

Cureus ◽  
2019 ◽  
Author(s):  
Victoria Krzywicki ◽  
Darin D Gopaul
2020 ◽  
Vol 31 (6) ◽  
pp. 892-894
Author(s):  
Keiji Yamanashi ◽  
Masatsugu Hamaji ◽  
Yukinori Matsuo ◽  
Noriko Kishi ◽  
Toyofumi Fengshi Chen-Yoshikawa ◽  
...  

Abstract There is dearth of data regarding the long-term survival outcomes of salvage surgery after stereotactic body radiotherapy for early-stage non-small-cell lung cancer, as previous studies have included a short follow-up period. There is also scarce information on the management of re-relapse in previous studies. This study examined the long-term survival outcomes of patients who underwent salvage surgery for isolated local relapse (LR). We reviewed consecutive patients who underwent salvage surgery for isolated LR after stereotactic body radiotherapy for early-stage non-small-cell lung cancer between 1999 and 2015. All patients were followed up until death or at least 5 years from salvage surgery. Twelve patients were included for analysis. The median follow-up from isolated LR was 62.4 (range: 14.3–152.1) months. The 5-year overall survival rate was 58.3%, updated from 79.5% in our previous report. During the interim, new re-relapses did not occur, whereas there were 5 additional deaths. The median survival after re-relapse was 32.6 months. Our follow-up report confirmed that our patient selection for salvage surgery appeared to be appropriate and that long-term follow-up is required to assess the outcomes of patients undergoing salvage surgery. Long-term follow-up would provide detailed information on late re-relapses, treatment and outcomes of re-relapses and mortality from any causes.


2017 ◽  
Vol 2017 ◽  
pp. 1-8
Author(s):  
Bao-Tian Huang ◽  
Wu-Zhe Zhang ◽  
Li-Li Wu ◽  
Pei-Xian Lin ◽  
Jia-Yang Lu

Purpose. The consistency for predicting local control (LC) data using biophysical models for stereotactic body radiotherapy (SBRT) treatment of lung cancer is unclear. This study aims to compare the results calculated from different models using the treatment planning data. Materials and Methods. Treatment plans were designed for 17 patients diagnosed with primary non-small cell lung cancer (NSCLC) using 5 different fraction schemes. The Martel model, Ohri model, and the Tai model were used to predict the 2-year LC value. The Gucken model, Santiago model, and the Tai model were employed to estimate the 3-year LC data. Results. We found that the employed models resulted in completely different LC prediction except for the Gucken and the Santiago models which exhibited quite similar 3-year LC data. The predicted 2-year and 3-year LC values in different models were not only associated with the dose normalization but also associated with the employed fraction schemes. The greatest difference predicted by different models was up to 15.0%. Conclusions. Our results show that different biophysical models influence the LC prediction and the difference is not only correlated to the dose normalization but also correlated to the employed fraction schemes.


2014 ◽  
Vol 10 (4) ◽  
pp. 523-528 ◽  
Author(s):  
Alfredo Tartarone ◽  
Rosa Lerose ◽  
Raffaele Ardito ◽  
Laura Troiani ◽  
Beatrice Tedesco ◽  
...  

2014 ◽  
Vol 5 (4) ◽  
pp. 349-353 ◽  
Author(s):  
Yujie Zhong ◽  
Qiuhong Zhang ◽  
Wenjing Deng ◽  
Yuping Zhang ◽  
Zongjuan Ming ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document